WordNet

(medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 乳癌予防のための選択的エストロゲン受容体調節因子およびアロマターゼ阻害剤 selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention
2. 非転移性ホルモン受容体陽性乳癌に対する補助内分泌療法 adjuvant endocrine therapy for non metastatic hormone receptor positive breast cancer
3. 転移性ホルモン受容体陽性乳癌に対する治療アプローチ：内分泌療法 treatment approach to metastatic hormone receptor positive breast cancer endocrine therapy
4. 胸部子宮内膜症：病因、疫学、および病理 thoracic endometriosis pathogenesis epidemiology and pathology
5. 選択的エストロゲン受容体モジュレーターの作用機序 mechanisms of action of selective estrogen receptor modulators

Reversal effects of Raloxifene on paclitaxel resistance in two MDR breast cancer cells.

Xu L1,2, Lei J1, Jiang D1, Zhou L1, Wang S1,3, Fan W1,4.
Cancer biology & therapy.Cancer Biol Ther.2015 Nov 3:0. [Epub ahead of print]
Raloxifene hydrochloride (RAL), one of second generation of selective estrogen receptor modulators (SERMs), is usually used in preventing osteoporosis and breast cancer. The present study evaluated whether Raloxifene might sensitize multidrug resistant (MDR) breast cancers to chemotherapies, especia
PMID 26529585

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial.

Fujimura T1, Takahashi S2, Kume H3, Urano T4,5, Takayama K6,7, Yamada Y8, Suzuki M9, Fukuhara H10, Nakagawa T11, Inoue S12,13, Homma Y14.
BMC cancer.BMC Cancer.2015 Nov 2;15:836. doi: 10.1186/s12885-015-1871-z.
BACKGROUNDS: Durability of androgen-deprivation therapy (ADT) for prostate cancer (PC) is limited. Additional selective estrogen receptor modulators (SERMs) may prolong the durability of ADT, because androgen and estrogen signaling drive PC progression.METHODS: Men with treatment-naïve bone metasta
PMID 26526623

Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.

van Meurs HS1, van der Velden J1, Buist MR1, van Driel WJ2, Kenter GG1, van Lonkhuijzen LR1.
Acta obstetricia et gynecologica Scandinavica.Acta Obstet Gynecol Scand.2015 Nov;94(11):1269-75. doi: 10.1111/aogs.12720. Epub 2015 Sep 15.
INTRODUCTION: The aim of this study was to retrospectively determine the objective response rate to hormone therapy (HT) for patients with a measurable adult granulosa cell tumor (GCT) of the ovary in a consecutive series of patients.MATERIAL AND METHODS: All patients with an adult GCT who were trea
PMID 26230362